Searched for
OXFORD AZ
Covishield vaccine: Plea filed in SC seeking formation of expert panel to study side-effects, risk factorsA petition filed in the Supreme Court seeks the formation of a medical panel from AIIMS, Delhi to study Covishield's side effects. It deman...- Serum Institute could earn $4 billion from vaccine sales in 2 yearsPune's Serum Institute of India, the world’s largest vaccine manufacturer, is expected to generate $4 billion in revenues through its Covid...
- SII seeks Government's nod to give 50 lakh Covishield doses to UK, says won't affect India's vaccination driveIn a communique to Union Health Secretary Rajesh Bhushan on Tuesday, the Director of Government and Regulatory Affairs at the Pune-based Se...
- Serum Institute of India receives Health Canada approval to supply vaccines to CanadaCanada has an agreement with AZ to receive 20 million doses. The approval to Verity Pharmaceuticals Inc./Serum Institute of India product h...
- Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: StudiesIsraeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on mo...
- South Africa denies asking Serum to take back 1 million vaccine dosesA phase I/II trial conducted by University of Witwatersrand and Oxford University on 2,000 volunteers with a median age of 31 years found t...
- Covid vaccine drive from Jan 13; SII, Bharat Bio make peaceThe Co-WIN app announced by the government will be central to the registration process.
- SII can supply 10m doses to govt in January: Adar PoonawallaThe company is ready to start rolling out supplies of its Covishield vaccine in a week’s time, Poonawalla said. SII is waiting for a formal...
- Serum's chances for Covishield nod rise after UK regulator approves Oxford COVID-19 vaccineThe SEC was called soon after the UK regulator authorised Oxford University/AstraZeneca’s Covid-19 vaccine for use. The approval by UK regu...
- AstraZeneca-Oxford vaccine still under review: UK drug regulatorThe subject expert committee in India is awaiting a nod from the UK's regulator to sign off on the marketing authorisation for SII to deliv...
- India in touch with UK drug officials on Oxford Covid-19 vaccine: Vaccine Task Force Committee“India’s drug regulator is in touch with UK drug authorities on the approval progress of the AZ/Oxford vaccine trial,” Vinod Paul, head of ...
- India may have 500 million Covid-19 vaccine doses by MarchCompanies such as Zydus Cadila, Bharat Biotech, Dr Reddys-Gamaleya Institute, Serum Institute-AstraZeneca and Gennova are expected to submi...
- Single Covid-19 vaccine dose or double? Data put regulators in a fixThe US Food and Drug Administration has released its findings on the Pfizer/BioNtech efficacy data where it suggested that the vaccine at a...
- AZ-Oxford vaccine safe & efficacious: Interim analysis“ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic Covid-19 in this interim analysi...
- The curious case of AstraZeneca-Oxford vaccineThe company announced that in a small subgroup of the trial participants the vaccine showed better efficacy when administered a half dose f...
- Covid-19 vaccines are coming to India, but are we ready for a rollout?While most experts are confident that India will get a vaccine, their concern is how the country will scale up to vaccinate its 1.3 billion...
- Serum Institute of India to also halt trial of the Oxford-AstraZeneca vaccine candidateAZ on Wednesday morning said that it was temporarily halting the trial of the vaccine candidate after one of the participants developed "un...
- India may get COVID-19 vaccine by early 2021, says Bernstein ResearchWhile the vaccine could be available at USD 3-6 (Rs 225 to Rs 550) per dose, herd immunity might be two years away due to implementation ch...
- Serum Institute initiates phase 2, 3 clinical study for potential COVID-19 vaccineAccording to the Clinical Trial Registry India, the scientific title of the study says that phase 2/3 clinical trial will be observer-blind...
- Serum Institute to price Covid-19 vaccine at $3 per dose for India and lower middle income nationsAs part of the agreement SII will also get upfront capital of $150 mn via the Bill and Melinda Gates Foundation to help the company increas...
Load More
